Low-dose Gonal-f® in Ovulation Induction

Summary

This is a prospective, multicenter, open-label, comparative and parallel-group study of ovulation induction evaluating tailoring of Recombinant follicle stimulating hormone (FSH) treatment using the Gonal-f® prefilled pen in World Health Organization (WHO) Type 2 anovulatory subjects who have previously failed to conceive with clomifene treatment.

Timeline

Start

2013-07

Primary completion

2014-03

Completion

2014-11

Drugs

Indications